30-Second Takeaway
- Smart bioactive sutures and engineered dermal matrices may meaningfully accelerate tendon, skin, and diabetic wound repair.
- Injectable osteoinductive hydrogels and customized titanium meshes are refining maxillofacial reconstruction around implants.
- Organ-preserving strategies for nasal vestibule SCC and fluorescence-guided margins may reduce ablative extent and adjuvant therapy.
- Submandibular gland preservation during neck dissection appears oncologically safe in carefully selected early OSCC.
- New vascularized in vitro dermis models should speed preclinical testing of wound dressings and biomaterials relevant to plastic surgery.
Week ending March 14, 2026
Emerging tools in craniofacial reconstruction, wound healing, and head–neck oncology
Bioactive, conductive “smart” sutures plus microcurrent accelerate tendon and skin repair in rats
This preclinical study describes a biomimetic suture coated with thiolated chitosan microgels, basic FGF, and conductive polypyrrole (SHTP@bFGF). The coating improves mechanical compliance with tendon and skin, provides antibacterial surface properties, and enables pH/GSH-triggered bFGF release. Combined with transcutaneous low-voltage microampere stimulation, these sutures markedly enhanced Achilles tendon and full-thickness skin healing in rats. The system reduced infection risk and promoted more regenerative tendon–skin repair than conventional sutures in these models. Its modular coating strategy is compatible with commercial suture substrates, but there are no human data yet.
Human dermis-specific interwoven ECM improves diabetic wound closure versus non-structured matrices in rats
Investigators engineered a human cell–derived acellular interwoven extracellular matrix (iECM) that mimics dermal collagen architecture and stiffness. The decellularized iECM had an elastic modulus around 4 MPa, within the native human dermal range. In diabetic full-thickness rat wounds, iECM accelerated healing by about 80% compared with non-structured ECM scaffolds. iECM promoted granulation, angiogenesis, resolution of inflammation, organized collagen deposition, and complete re-epithelialization. These data suggest an all-biologic, dermis-mimetic matrix could outperform current acellular dermal substitutes in chronic diabetic wounds, pending clinical trials.
MSC-mimicking nanovesicle hydrogel outperforms Bio-Oss for maxillofacial bone regeneration in preclinical models
Researchers developed an injectable, tissue-adhesive PEG hydrogel (PEG-pp@nMSC@MT) delivering MSC-derived nanovesicles and melatonin for maxillofacial defects. The hydrogel forms quickly in situ, exhibits strong adhesion under masticatory forces, and incorporates an MMP2-cleavable peptide for enzyme-responsive release. Released nanovesicles and melatonin modulate inflammation, promote BMMSC osteogenesis, and shift macrophages toward an M2 phenotype. In preclinical comparisons, this platform showed superior biodegradability and osteoinductive capacity versus Bio-Oss, a current clinical graft standard. The data support a combined immunomodulatory and osteogenic strategy for craniofacial bone repair, but human evidence is absent.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.